Global Liquid Biopsy Products Market Analysis and Forecast 2024-2030

Global Liquid Biopsy Products Market Analysis and Forecast 2024-2030


Summary

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.

According to APO Research, The global Liquid Biopsy Products market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liquid Biopsy Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Liquid Biopsy Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Liquid Biopsy Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Liquid Biopsy Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Liquid Biopsy Products include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics and Cynvenio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Liquid Biopsy Products, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Liquid Biopsy Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Liquid Biopsy Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liquid Biopsy Products revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liquid Biopsy Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Liquid Biopsy Products revenue, projected growth trends, production technology, application and end-user industry.

Liquid Biopsy Products segment by Company

RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Liquid Biopsy Products segment by Type

CTCs
ctDNA
Exosomes
Liquid Biopsy Products segment by Application

Blood Sample
Urine Sample
Other Bio Fluids
Liquid Biopsy Products segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid Biopsy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liquid Biopsy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid Biopsy Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Liquid Biopsy Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Liquid Biopsy Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liquid Biopsy Products revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Liquid Biopsy Products Market by Type
1.2.1 Global Liquid Biopsy Products Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 CTCs
1.2.3 ctDNA
1.2.4 Exosomes
1.3 Liquid Biopsy Products Market by Application
1.3.1 Global Liquid Biopsy Products Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Blood Sample
1.3.3 Urine Sample
1.3.4 Other Bio Fluids
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Liquid Biopsy Products Market Dynamics
2.1 Liquid Biopsy Products Industry Trends
2.2 Liquid Biopsy Products Industry Drivers
2.3 Liquid Biopsy Products Industry Opportunities and Challenges
2.4 Liquid Biopsy Products Industry Restraints
3 Global Growth Perspective
3.1 Global Liquid Biopsy Products Market Perspective (2019-2030)
3.2 Global Liquid Biopsy Products Growth Trends by Region
3.2.1 Global Liquid Biopsy Products Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Liquid Biopsy Products Market Size by Region (2019-2024)
3.2.3 Global Liquid Biopsy Products Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Liquid Biopsy Products Revenue by Players
4.1.1 Global Liquid Biopsy Products Revenue by Players (2019-2024)
4.1.2 Global Liquid Biopsy Products Revenue Market Share by Players (2019-2024)
4.1.3 Global Liquid Biopsy Products Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Liquid Biopsy Products Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Liquid Biopsy Products Key Players Headquarters & Area Served
4.4 Global Liquid Biopsy Products Players, Product Type & Application
4.5 Global Liquid Biopsy Products Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Liquid Biopsy Products Market CR5 and HHI
4.6.2 Global Top 5 and 10 Liquid Biopsy Products Players Market Share by Revenue in 2023
4.6.3 2023 Liquid Biopsy Products Tier 1, Tier 2, and Tier 3
5 Liquid Biopsy Products Market Size by Type
5.1 Global Liquid Biopsy Products Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Liquid Biopsy Products Revenue by Type (2019-2030)
5.3 Global Liquid Biopsy Products Revenue Market Share by Type (2019-2030)
6 Liquid Biopsy Products Market Size by Application
6.1 Global Liquid Biopsy Products Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Liquid Biopsy Products Revenue by Application (2019-2030)
6.3 Global Liquid Biopsy Products Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 RainDanceTechnologies
7.1.1 RainDanceTechnologies Comapny Information
7.1.2 RainDanceTechnologies Business Overview
7.1.3 RainDanceTechnologies Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.1.4 RainDanceTechnologies Liquid Biopsy Products Product Portfolio
7.1.5 RainDanceTechnologies Recent Developments
7.2 Biocartis
7.2.1 Biocartis Comapny Information
7.2.2 Biocartis Business Overview
7.2.3 Biocartis Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.2.4 Biocartis Liquid Biopsy Products Product Portfolio
7.2.5 Biocartis Recent Developments
7.3 Qiagen
7.3.1 Qiagen Comapny Information
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.3.4 Qiagen Liquid Biopsy Products Product Portfolio
7.3.5 Qiagen Recent Developments
7.4 Guardant Health
7.4.1 Guardant Health Comapny Information
7.4.2 Guardant Health Business Overview
7.4.3 Guardant Health Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.4.4 Guardant Health Liquid Biopsy Products Product Portfolio
7.4.5 Guardant Health Recent Developments
7.5 MDxHealth
7.5.1 MDxHealth Comapny Information
7.5.2 MDxHealth Business Overview
7.5.3 MDxHealth Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.5.4 MDxHealth Liquid Biopsy Products Product Portfolio
7.5.5 MDxHealth Recent Developments
7.6 Pathway Genomics
7.6.1 Pathway Genomics Comapny Information
7.6.2 Pathway Genomics Business Overview
7.6.3 Pathway Genomics Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.6.4 Pathway Genomics Liquid Biopsy Products Product Portfolio
7.6.5 Pathway Genomics Recent Developments
7.7 NeoGenomics Laboraories
7.7.1 NeoGenomics Laboraories Comapny Information
7.7.2 NeoGenomics Laboraories Business Overview
7.7.3 NeoGenomics Laboraories Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.7.4 NeoGenomics Laboraories Liquid Biopsy Products Product Portfolio
7.7.5 NeoGenomics Laboraories Recent Developments
7.8 Sysmex Inostics
7.8.1 Sysmex Inostics Comapny Information
7.8.2 Sysmex Inostics Business Overview
7.8.3 Sysmex Inostics Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.8.4 Sysmex Inostics Liquid Biopsy Products Product Portfolio
7.8.5 Sysmex Inostics Recent Developments
7.9 Cynvenio
7.9.1 Cynvenio Comapny Information
7.9.2 Cynvenio Business Overview
7.9.3 Cynvenio Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.9.4 Cynvenio Liquid Biopsy Products Product Portfolio
7.9.5 Cynvenio Recent Developments
7.10 Menarini Silicon Biosystems
7.10.1 Menarini Silicon Biosystems Comapny Information
7.10.2 Menarini Silicon Biosystems Business Overview
7.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Product Portfolio
7.10.5 Menarini Silicon Biosystems Recent Developments
7.11 Adaptive Biotechnologies
7.11.1 Adaptive Biotechnologies Comapny Information
7.11.2 Adaptive Biotechnologies Business Overview
7.11.3 Adaptive Biotechnologies Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.11.4 Adaptive Biotechnologies Liquid Biopsy Products Product Portfolio
7.11.5 Adaptive Biotechnologies Recent Developments
7.12 Biocept
7.12.1 Biocept Comapny Information
7.12.2 Biocept Business Overview
7.12.3 Biocept Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.12.4 Biocept Liquid Biopsy Products Product Portfolio
7.12.5 Biocept Recent Developments
7.13 Angle plc
7.13.1 Angle plc Comapny Information
7.13.2 Angle plc Business Overview
7.13.3 Angle plc Liquid Biopsy Products Revenue and Gross Margin (2019-2024)
7.13.4 Angle plc Liquid Biopsy Products Product Portfolio
7.13.5 Angle plc Recent Developments
8 North America
8.1 North America Liquid Biopsy Products Revenue (2019-2030)
8.2 North America Liquid Biopsy Products Revenue by Type (2019-2030)
8.2.1 North America Liquid Biopsy Products Revenue by Type (2019-2024)
8.2.2 North America Liquid Biopsy Products Revenue by Type (2025-2030)
8.3 North America Liquid Biopsy Products Revenue Share by Type (2019-2030)
8.4 North America Liquid Biopsy Products Revenue by Application (2019-2030)
8.4.1 North America Liquid Biopsy Products Revenue by Application (2019-2024)
8.4.2 North America Liquid Biopsy Products Revenue by Application (2025-2030)
8.5 North America Liquid Biopsy Products Revenue Share by Application (2019-2030)
8.6 North America Liquid Biopsy Products Revenue by Country
8.6.1 North America Liquid Biopsy Products Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Liquid Biopsy Products Revenue by Country (2019-2024)
8.6.3 North America Liquid Biopsy Products Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Liquid Biopsy Products Revenue (2019-2030)
9.2 Europe Liquid Biopsy Products Revenue by Type (2019-2030)
9.2.1 Europe Liquid Biopsy Products Revenue by Type (2019-2024)
9.2.2 Europe Liquid Biopsy Products Revenue by Type (2025-2030)
9.3 Europe Liquid Biopsy Products Revenue Share by Type (2019-2030)
9.4 Europe Liquid Biopsy Products Revenue by Application (2019-2030)
9.4.1 Europe Liquid Biopsy Products Revenue by Application (2019-2024)
9.4.2 Europe Liquid Biopsy Products Revenue by Application (2025-2030)
9.5 Europe Liquid Biopsy Products Revenue Share by Application (2019-2030)
9.6 Europe Liquid Biopsy Products Revenue by Country
9.6.1 Europe Liquid Biopsy Products Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Liquid Biopsy Products Revenue by Country (2019-2024)
9.6.3 Europe Liquid Biopsy Products Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Liquid Biopsy Products Revenue (2019-2030)
10.2 China Liquid Biopsy Products Revenue by Type (2019-2030)
10.2.1 China Liquid Biopsy Products Revenue by Type (2019-2024)
10.2.2 China Liquid Biopsy Products Revenue by Type (2025-2030)
10.3 China Liquid Biopsy Products Revenue Share by Type (2019-2030)
10.4 China Liquid Biopsy Products Revenue by Application (2019-2030)
10.4.1 China Liquid Biopsy Products Revenue by Application (2019-2024)
10.4.2 China Liquid Biopsy Products Revenue by Application (2025-2030)
10.5 China Liquid Biopsy Products Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Liquid Biopsy Products Revenue (2019-2030)
11.2 Asia Liquid Biopsy Products Revenue by Type (2019-2030)
11.2.1 Asia Liquid Biopsy Products Revenue by Type (2019-2024)
11.2.2 Asia Liquid Biopsy Products Revenue by Type (2025-2030)
11.3 Asia Liquid Biopsy Products Revenue Share by Type (2019-2030)
11.4 Asia Liquid Biopsy Products Revenue by Application (2019-2030)
11.4.1 Asia Liquid Biopsy Products Revenue by Application (2019-2024)
11.4.2 Asia Liquid Biopsy Products Revenue by Application (2025-2030)
11.5 Asia Liquid Biopsy Products Revenue Share by Application (2019-2030)
11.6 Asia Liquid Biopsy Products Revenue by Country
11.6.1 Asia Liquid Biopsy Products Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Liquid Biopsy Products Revenue by Country (2019-2024)
11.6.3 Asia Liquid Biopsy Products Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Liquid Biopsy Products Revenue (2019-2030)
12.2 MEALA Liquid Biopsy Products Revenue by Type (2019-2030)
12.2.1 MEALA Liquid Biopsy Products Revenue by Type (2019-2024)
12.2.2 MEALA Liquid Biopsy Products Revenue by Type (2025-2030)
12.3 MEALA Liquid Biopsy Products Revenue Share by Type (2019-2030)
12.4 MEALA Liquid Biopsy Products Revenue by Application (2019-2030)
12.4.1 MEALA Liquid Biopsy Products Revenue by Application (2019-2024)
12.4.2 MEALA Liquid Biopsy Products Revenue by Application (2025-2030)
12.5 MEALA Liquid Biopsy Products Revenue Share by Application (2019-2030)
12.6 MEALA Liquid Biopsy Products Revenue by Country
12.6.1 MEALA Liquid Biopsy Products Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Liquid Biopsy Products Revenue by Country (2019-2024)
12.6.3 MEALA Liquid Biopsy Products Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings